Literature DB >> 25072877

One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors.

Ornelio Rosati1, Federica Messina2, Azzurra Pelosi2, Massimo Curini2, Vanessa Petrucci3, Jürg Gertsch3, Andrea Chicca4.   

Abstract

Δ(9)-tetrahydrocannabinol (Δ(9)-THC) is the major psychoactive cannabinoid in hemp (Cannabis sativa L.) and responsible for many of the pharmacological effects mediated via cannabinoid receptors. Despite being the major cannabinoid scaffold in nature, Δ(9)-THC double bond isomers remain poorly studied. The chemical scaffold of tetrahydrocannabinol can be assembled from the condensation of distinctly substituted phenols and monoterpenes. Here we explored a microwave-assisted one pot heterogeneous synthesis of Δ(3)-THC from orcinol (1a) and pulegone (2). Four Δ(3)-THC analogues and corresponding Δ(4a)-tetrahydroxanthenes (Δ(4a)-THXs) were synthesized regioselectively and showed differential binding affinities for CB1 and CB2 cannabinoid receptors. Here we report for the first time the CB1 receptor binding of Δ(3)-THC, revealing a more potent receptor binding affinity for the (S)-(-) isomer (hCB1Ki = 5 nM) compared to the (R)-(+) isomer (hCB1Ki = 29 nM). Like Δ(9)-THC, also Δ(3)-THC analogues are partial agonists at CB receptors as indicated by [(35)S]GTPγS binding assays. Interestingly, the THC structural isomers Δ(4a)-THXs showed selective binding and partial agonism at CB2 receptors, revealing a simple non-natural natural product-derived scaffold for novel CB2 ligands.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cannabinoid receptor; Cannabis sativa; Heterogeneous assisted catalysis; Tetrahydroxanthene; Ytterbium triflate; Δ(3)-Tetrahydrocannabinol; Δ(9)-Tetrahydrocannabinol

Mesh:

Substances:

Year:  2014        PMID: 25072877     DOI: 10.1016/j.ejmech.2014.07.062

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  6 in total

1.  Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.

Authors:  Julie A Marusich; Jenny L Wiley; Timothy W Lefever; Purvi R Patel; Brian F Thomas
Journal:  Neuropharmacology       Date:  2017-11-04       Impact factor: 5.250

2.  Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake.

Authors:  Andrea Chicca; Simon Nicolussi; Ruben Bartholomäus; Martina Blunder; Alejandro Aparisi Rey; Vanessa Petrucci; Ines Del Carmen Reynoso-Moreno; Juan Manuel Viveros-Paredes; Marianela Dalghi Gens; Beat Lutz; Helgi B Schiöth; Michael Soeberdt; Christoph Abels; Roch-Philippe Charles; Karl-Heinz Altmann; Jürg Gertsch
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

3.  4'-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation.

Authors:  Andrea Chicca; Maria Salomé Gachet; Vanessa Petrucci; Wolfgang Schuehly; Roch-Philippe Charles; Jürg Gertsch
Journal:  J Neuroinflammation       Date:  2015-05-13       Impact factor: 8.322

4.  The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.

Authors:  Eric W Bow; John M Rimoldi
Journal:  Perspect Medicin Chem       Date:  2016-06-28

5.  Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.

Authors:  Vanessa Petrucci; Andrea Chicca; Sandra Glasmacher; Janos Paloczi; Zongxian Cao; Pal Pacher; Jürg Gertsch
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

6.  Synthesis of [13C4]-labeled ∆9-tetrahydrocannabinol and 11-nor-9-carboxy-∆9-tetrahydrocannabinol as internal standards for reducing ion suppressing/alteration effects in LC/MS-MS quantification.

Authors:  Morten Karlsen; Huiling Liu; Jon Eigill Johansen; Bård Helge Hoff
Journal:  Molecules       Date:  2014-09-01       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.